Test to Treat Townhall 2: Prescriptive Authority is Here. What’s Next?
ON-DEMAND RECORDING COMING SOON.
Now that the FDA has given pharmacists the greenlight to prescribe COVID-19 antiviral Paxlovid following specific protocols, you’re likely wondering, ”What’s next?” Tune in to hear David Pope, PharmD, CDE, EVP Innovation & Industry Relations and Shelley Hansell, EVP, Client Relations & RCM Product Management discuss what this means for pharmacy today, and the crucial next steps to operationalize test and treat in the pharmacy.
SPEAKERS
David Pope
PharmD, CDE, Chief Pharmacy Officer
David Pope is the Chief Pharmacy Officer at XiFin. he is a Certified Diabetes Educator (CDE) who is passionate about improving patient care through innovative ideas. He is the Chief Pharmacy Officer of XiFin Pharmacy Solutions and brings over a decade of experience in pharmacy consulting, medical informatics, transitions of care, and the integration of clinical services in the retail pharmacy space.
Shelley Hansell
EVP Client Relations & RCM Product Management, XiFin Pharmacy Solutions
Formerly, Shelley served as the executive vice president of client relations, and revenue cycle product management, responsible for building client partnerships and implementing products and services that mutually grow businesses. With nearly 20 years of domain experience, Shelley is well respected in the pharmacy industry for her revenue cycle management expertise as well as her ability to drive operational improvements aligned with medical billing policies.